jenny mollen tirzepatide was microdosing Tirzepatide, a GLP-1 weight loss drug usually used to treat those with diabetes, while taking a “cocktail of peptides.” https://trib.al/SuuHqOh Jenny Mollen drops truth bombs

The hypothalamus, particularly the arcuate nucleus, contains GLP-1 receptors that modulate hunger and satiety signals

Understanding how drops interact with these combinations is important

GLP-1RA Therapy as a Chronic Flux Perturbation System-Level Energy Flux Reorganization Under Weight Loss Therapy Most weight-loss interventionsincluding exercise [49], calorie restriction [50], cold exposure [51], and selected antidiabetic agents [10, 52]ultimately increase reliance on FAO, which supplies acetyl-CoA to sustain tricarboxylic acid (TCA) cycle activity and electron transport chain (ETC)coupled adenosine triphosphate (ATP) production

PlexusDx compounded semaglutide injection is administered from licensed 503A compounding pharmacies, ensuring pharmaceutical quality and consistency across all dose levels

Some lose 5 to 10% of body weight over six to twelve months

30%, p = 0.0004)